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Abstract 
We report the case of a girl with a novel mutation of the COL4A gene (c.2716+2T>C) present-
ing microcephaly, parenchymal hemorrhages, lissencephaly, and bilateral cataracts, associated 
with agenesis of the corpus callosum and hypoplasia of the optic nerve. COL4A1, located on 
chromosome 13, encodes the α1 chain of type IV collagen, a key component of the basement 
membrane in various organs, such as eye, brain, kidneys, and muscles. Different mutations 
have been described and may remain asymptomatic or determine porencephaly, cerebral 
hemorrhages, renal cysts, hematuria, and dysgenesis of the anterior segment of the eye. 
 © 2019 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
COL4A1, located on chromosome 13q34, encodes the α1 chain of type IV collagen, a non-
fibrillar protein expressed in the basement membrane of all tissues [1, 2]. In the eyes, COL4A1 
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is expressed in the conjunctiva, corneal endothelium and epithelium, trabecular meshwork, 
Schlemm’s canal, lens, retinal inner limiting membrane, Bruch’s membrane, and vessels [3]. 
Pathology resulting from the rare mutation of COL4A1 is extremely varied, with different 
intra- and interfamilial clinical phenotypes. Sporadic cases arise from de novo mutation and 
are characterized by severe clinical manifestations [4]. Age at onset is extremely variable, 
from fetal period to young adulthood, although cases of asymptomatic subjects or with late-
onset cerebral hemorrhages have been described [5]. The phenotype variability observed in 
the components of families carrying the same mutation suggests a role of environmental fac-
tors in gene expression, such as head traumas or use of oral anticoagulants [6, 7]. 
Several lesions of the central nervous system related to COL4A1 mutations have been de-
scribed, such as porencephaly, hydranencephaly, periventricular leukoencephalopathy, lis-
sencephaly, schizencephaly, cerebral calcifications, intracerebral and intraventricular hemor-
rhages, cerebellar atrophy, intracranial aneurysms, hydrocephalus, mild ventriculomegaly, 
abnormal basal ganglia [4], and microencephaly [8]. COL4A1 mutation is also related to renal 
alterations such as renal cysts, microscopic and macroscopic hematuria, renal agenesis and 
atrophy, and renovascular hypertension [9, 10]. Cardiac manifestations include Raynaud phe-
nomenon, supraventricular arrhythmias, and mitral valve prolapse [4]. Muscular involvement 
has also been reported, with increased serum creatine kinase concentration [11], muscle 
cramps, and myopathy [4]. One case of COL4A1 mutation has been linked with severe and re-
peated alveolar hemorrhages [10]. Numerous ocular manifestations have been observed, such 
as Axenfeld-Rieger anomaly, characterized by dysgenesis of the anterior chamber angle and 
of the aqueous drainage structures, iris hypoplasia, iridocorneal adhesions, and corectopia. 
Cataract, microcornea, Peters anomaly, corneal opacities, posterior embryotoxon, glaucoma, 
retinal arterial tortuosity, retinal hemorrhages, optic atrophy, and anophthalmos/microph-
thalmos have also been reported [4, 12]. 
We report the case of a girl with microencephaly, frontal lissencephaly, parenchymal 
hemorrhages, almost complete corpus callosum agenesis, and hypoplasia of the optic nerve 
who developed a bilateral cataract at 6 months of life and in whom a novel COL4A1 mutation 
was identified as the genetic cause. 
Case Presentation 
The patient was the second daughter of nonconsanguineous Caucasian parents. Her 
mother was 30 years old and her father was 35 years old. There was no known exposure to 
any teratogens. The mother was diagnosed with pregnancy diabetes and treated with insulin. 
Fetal ultrasound at the 32nd gestational week showed intrauterine growth retardation with-
out other associated findings. It was repeated at the 35th gestational week, detecting micro-
cephaly, ventricular dysmorphism, and cerebellar hypoplasia. The child was born at 38 gesta-
tional weeks via normal spontaneous delivery, with an APGAR score of 7 and 8 at 1 and 5 min 
after birth, respectively. Birth weight was 2,172 g (<3rd percentile), length was 44.9 cm (<3rd 
percentile), and cranial circumference was 29.9 cm (<3rd percentile). Brain magnetic reso-
nance imaging after 7 days showed enlargement of the periencephalic subarachnoid spaces, 
both under and over the tentorium, ventriculomegaly, almost complete corpus callosum agen-
esis, and cerebellar hemispheres and vermis hypoplasia. Porencephalic areas, delimited by 
hyperintense edges on T2-weighted images and hypointense edges on T1-weighted images, 
were observed in the cerebral parenchyma, and they were determined to be of hemorrhag- 
ic origin. Gyri defects with bilateral frontal and temporal lissencephaly were also present  
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(Fig. 1). One month later, a computed tomography scan was performed which revealed corti-
cal and subcortical diffuse periventricular calcifications (Fig. 2). 
At birth the girl presented slight muscular hypertonia which evolved into a spastic tetra-
paresis in the following months. At 6 months of age the infant presented episodes of seizures 
which were treated with antiepileptic medical therapy, achieving good control with no re-
lapses. 
At 5 days of age, ophthalmological examination detected marked hypoplasia of the optic 
nerve at the fundus oculi, while no anomalies of the anterior segment were observed (Fig. 3). 
At 6 months of age an ophthalmological reevaluation identified a nuclear cataract (Fig. 4) that 
prevented evaluation of the fundus oculi. The child underwent bilateral cataract extraction, 
without intraocular lens implantation, and anterior vitrectomy with capsulotomy by vitrec-
tome, with an uncomplicated postoperative course. One week after surgery she developed in-
creased intraocular pressure in the left eye, resistant to medical therapy, and 1 month later 
the right eye developed a pupillary membrane. Transconjunctival laser cyclophotocoagulation 
was performed on 360° in the left eye and the pupillary membrane was removed in the right 
eye. Subsequently, intraocular pressure in the left eye normalized with topical therapy and 
the optical axis of the right eye was free. Despite optical correction with positive lenses, visual 
acuity remained uncertain light perception in both eyes after the second surgery. 
Considering the patient’s clinical manifestations, sequencing of the COL4A1 gene was per-
formed. The test results were positive for the heterozygous mutation c.2716+2T>C, which af-
fects a consensus sequence for splicing. Both mother and father were negative for mutation. 
Discussion 
COL4A1 encodes the proα1 (IV) chain, which with the proα2 (IV) chain, encoded by the 
COL4A2 gene, leads to type IV collagen production. The two chains are assembled as hetero-
dimer with a 2:1 ratio (proα1 [IV] 2:proα2 [IV] 1). Both genes lie on chromosome 13. Type IV 
collagen is a nonfibrillar collagen and is the main component of the basement membrane of 
many tissues [4]. It consists of three major domains: the amino terminal 7S domain, which 
intervenes in intermolecular crosslinking and macromolecular organization, the central triple 
helix, and a carboxy-terminal domain, noncollagenous, which is responsible for the initiation 
of heterodimer assembly [13]. Mutations of COL4A1 are extremely rare and cause alteration 
of the basement membrane in many organs, including the eye. 
Typical central nervous system manifestations of COL4A1 mutations are microcephaly, 
porencephaly, lissencephaly, and dilatation of cerebral ventricles, and are also present in this 
novel mutation. Brain magnetic resonance imaging, performed on the 7th day of age, showed 
alterations compatible with brain hemorrhages. These likely occurred during intrauterine life, 
in accordance with previous reports on intracerebral hemorrhages before birth [1, 14], while 
late-onset brain hemorrhages are often associated with trauma [7]. In fact, the disease pre-
sents different clinical manifestations and age at onset, based on the type of mutation and en-
vironmental factors that influence the phenotype. 
This novel mutation is accompanied by two different entities and previously undescribed 
in association with the known mutations of COL4A1: almost complete agenesis of the corpus 
callosum and optic nerve hypoplasia. Type IV collagen plays a role in embryogenesis, angio-
genesis, cellular migration, and differentiation [15], which could explain the onset of the afore-
mentioned alterations. Spastic tetraparesis and epileptic crises could be attributed to the 
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numerous cerebral parenchymal hemorrhages, a manifestation often related to COL4A1 mu-
tations. 
The mechanism of cataract formation is not precisely determined, although a hypothesis 
related to oxidative stress has been proposed. Unfolded type IV collagen chains accumulate in 
rough endoplasmic reticulum whenever COL4A1 mutation c.2345 G>C is present. Progressive 
accumulation in rough endoplasmic reticulum causes oxidative stress and, if not opposed by 
other mechanisms, such as reduction of protein synthesis or increased clearance of unfolded 
protein, causes cell apoptosis, eventually leading to cataract development [13]. 
The patient also developed glaucoma in the left eye. The timing of the elevation of intra-
ocular pressure seems unlikely to be related to cataract surgery, although rare cases of early 
pediatric glaucoma after cataract surgery have been described. Our hypothesis is that the 
pathological basis of this case of glaucoma could have been an undocumented alteration to 
angle structures, frequently described in association with COL4A1 mutations. In addition, the 
child developed a fibrotic pupillary membrane after cataract extraction, a condition already 
described in other patients with COL4A1 mutation [12]. 
In conclusion, we report a case of optic nerve hypoplasia and almost complete corpus cal-
losum agenesis in a patient with disorders related to a novel mutation in COL4A1. An extensive 
research of the scientific literature did not find other cases with this mutation. It is recom-
mended to plan a follow-up, due to the unpredictable timing of onset of complications which 
are not always present at birth and could threaten the patient’s vision if left unchecked. 
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Fig. 1. a, b Brain magnetic resonance imaging showing optic nerve hypoplasia and almost complete corpus 
callosum. 
 
 
 
Fig. 2. Computed tomography scan showing subcortical diffuse periventricular calcifications. 
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Fig. 3. a, b Hypoplasia of the optic nerve head. 
 
 
 
Fig. 4. a, b Bilateral nuclear cataract before surgery. 
 
